In an interview with CGTN, Nobel laureate Randy Schekman discusses the urgent need for new therapeutic targets, the role of alpha-synuclein in Parkinson's disease, and how research into irisin – a peptide linked to exercise – could open new avenues for treatment.

From understanding disease mechanisms to exploring new treatment possibilities, scientific discovery offers hope for the future. 

Executive producer: Zhang Jingwen

Producer: Yang Sha

Reporter and editor: Zhang Yuying

Videographer: Wang Hongjie 

Copy editors: Zhou Jun, Chen Chen, Zaruhi

Visual designer: Du Chenxin